An observational study of first-line valproate monotherapy in focal epilepsy

European Journal of Neurology

Volumn 15, Issue 1, 2008, Pages 66-72

  Jedrzejczak J ^a,b   Kuncikova M ^c   Magureanu, S ^d  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^c Faculty Hospital Ostrava   (Czech Republic)

^d Alexandru Obregia Psychiatric Hospital Bucharest   (Romania)

Author keywords

Clinical trial; Efficacy; Focal epilepsy; Safety; Valproate

Indexed keywords

CHRONO; UNCLASSIFIED DRUG; VALPROIC ACID;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL DISEASE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SKIN DISEASE; STATISTICAL ANALYSIS; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; VOMITING; WEIGHT GAIN;

ADOLESCENT; ADULT; AGE FACTORS; ANTICONVULSANTS; BRAIN DISEASES; CHILD; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSIES, PARTIAL; EPILEPSY; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN DISEASES; TREATMENT OUTCOME; VALPROIC ACID; WEIGHT GAIN;

EID: 37249005804     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.02003.x     Document Type: Article

References (18)

1. Moran NF, Poole K, Bell G, et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti-epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure 2004 13 : 425 433.
2. Semah F, Picot MC, Derambure P, et al. The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey. Epileptic Disorders 2004 6 : 255 265.
3. Legros B, Boon P, Dejonghe P, et al. Opinion of Belgian neurologists on antiepileptic drugs: Belgian study on epilepsy treatment (BESET). Acta Neurologica Scandinavica 2007 115 : 97 103.
4. Sillanpää M. Carbamazepine. In : Shorvon SD, Perucca E, Fish D, Dodson E, eds. The Treatment of Epilepsy, 2nd edn. Blackwell Science Ltd., Oxford, 2004 : 345 357.
5. Beydoun A, Sackellares JC, Shu V. Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: a double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. Neurology 1997 48 : 182 188.
6. Christe W, Kramer G, Vigonius U, et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Research 1997 26 : 451 460.
7. Richens A, Davidson DL, Cartlidge NE, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. Journal of Neurology, Neurosurgery, and Psychiatry 1994 57 : 682 687.
8. Verity CM, Hosking G, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Developmental Medicine and Child Neurology 1995 37 : 97 108.
9. Heller AJ, Chesterman P, Elwes RD, et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. Journal of Neurology, Neurosurgery, and Psychiatry 1995 58 : 44 50.
10. de Silva M, MacArdle B, McGowan M, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996 347 : 709 713.
11. Reynolds EH, Heller AJ, Chadwick D. Valproate versus carbamazepine for seizures. The New England Journal of Medicine 1993 328 : 207 208.
12. Czapinski P, Terczynski A. Open randomized comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Neurologia i Neurochirurgia Polska 1996 30 : 419 426.
13. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989 30 : 389 399.
14. National Institute for Mental Health. Clinical global impressions. In : Guy W, ed. ECDEU Assessment Manual for Psychopharmacology. Rockville : National Institute for Mental Health, 1976 : 218 222.
15. Shorvon SD. The choice of drugs and approaches to drug treatment in partial epilepsy. In : Shorvon SD, Perucca E, Fish D, Dodson E, eds. 2nd edn. Blackwell Science Ltd., Oxford, 2004 : 317 333
16. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002 16 : 695 714.
17. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004 62 : 1252 1260.
18. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007 369 : 1000 1015.